Table 2.
CLL international prognostic index validation dataset. Adapted from [19]
| CLL IPI score | Patients (%) | Median OS (95% CI) | 5 year OS (95% CI) | 10 year OS (95% CI) | |
|---|---|---|---|---|---|
| Low | 0–1 | 186 (32%) | NR | 90.7% (86.4–95.1) | 86.5% (80.5–92.4) |
| Intermediate | 2–3 | 200 (34%) | 104 (84–123) | 79.8% (83.9–85.8) | 40.1% (29.3–50.9) |
| High | 4–6 | 147 (25%) | 63 (51–73) | 52.8% (44.5–61.1) | 16.1% (6.7–25.4) |
| Very high | 7–10 | 52 (9%) | 31 (20–39) | 18.6% (7.5–29.7) | 0% (NE) |
NR not reached, NE not evaluable